Surgical Therapy of the Thyroid Papillary Carcinoma in Children: Experience With 56 Patients <16 Years Old

Size: px
Start display at page:

Download "Surgical Therapy of the Thyroid Papillary Carcinoma in Children: Experience With 56 Patients <16 Years Old"

Transcription

1 Surgical Therapy of the Thyroid Papillary Carcinoma in Children: Experience With 56 Patients <16 Years Old By Claudio Spinelli, Alessia Bertocchini, Alessandro Antonelli, and Paolo Miccoli Pisa, Italy Background/Purpose: This article is an anatomic, clinical, therapeutic, and prognostic assessment of 56 children 16 years of age or younger, who underwent a surgical operation for thyroid papillary carcinoma from April 1988 to December 2001 in the Department of General Surgery at the University of Pisa. Of these 56 patients, 22 are Belarus children (39%) in whom carcinoma developed after the nuclear accident in Chernobyl in April 1986, whereas 34 (61%) are children with differentiated nonirradiated tumors. The purpose of this work was to compare the group of children who had radiation-induced thyroid carcinoma with the group affected by non radiation-induced carcinoma to evaluate if there are significant clinical, anatomic, and prognostic differences between them and to identify the best surgical strategy to adopt. Results: At the time of clinical presentation, the tumor was limited to the thyroid gland in 28 cases (50%), whereas in the others, in 24 cases (43%) metastases in the neck lymph nodes were present or had infiltrated the extrathyroid tissues as was seen in 4 cases (7%). The surgical operation was a total thyroidectomy in 37 cases (66%), whereas in 19 patients with radiation-induced carcinoma it was a hemithyroidectomy followed by a completion of thyroidectomy in Pisa (34%). The histologic examination showed multifocal sites of papillary adenocarcinoma in the gland in 23% of cases, and both lobes of the thyroid gland were involved with tumor in 23% of patients. The postsurgical follow-up showed a mortality rate of 0% and a recurrence rate of 33.5% (64% radiation-induced carcinoma v 3% non radiation-induced carcinoma; P.0001). At the moment, 8 of 22 cases (36%) with radiation-induced carcinoma are free of disease versus 33 of 34 (97%) with non radiation-induced carcinoma (P.0001). Conclusions: These findings show carcinoma of the thyroid in children has a low risk of mortality but a high risk of recurrence. Children with radiation-induced thyroid carcinoma are more likely to have a recurrence of the disease. Total thyroidectomy for the treatment of both radiationinduced and non radiation-induced carcinomas appears to represent, on the basis of these results, the best therapeutic option. J Pediatr Surg 39: Elsevier Inc. All rights reserved. INDEX WORDS: Childhood papillary thyroid cancer, irradiated thyroid cancer, Chernobyl nuclear accident, total thyroidectomy. THYROID CARCINOMA in children is a rare pathology; it comprises 3% of all tumors in children with an annual incidence of 0.2 to 0.4 per million children. 1,2 In 1998 the annual incidence of thyroid cancer in the United States was about 18,000 new cases, and it results in approximately 1,200 deaths each year. 3 Since the middle of the 1970s a decrease in carcinoma incidence owing to a more limited use of radiation in the therapy of benign pathologies of the head and neck has been observed, whereas since 1990 a 62-fold increase of carcinoma incidence has been recorded in children who live in Belarus, Ukraine and the Briansk territory after the nuclear accident at the Chernobyl nuclear plant. 4-7 In children, papillary thyroid carcinoma (PTC) has an initial clinical presentation and a follow-up different From the Cathedral of Pediatric Surgery, Department of Surgery, University of Pisa, Pisa, Italy. Address reprint requests to Claudio Spinelli, Cattedra Di Chirurgia Pediatrica, Dipartimento Di Chirurgia- Universita Degli Studi Di Pisa, Via Roma, Pisa, Italy Elsevier Inc. All rights reserved /04/ $30.00/0 doi: /j.jpedsurg from that in adults. In adults the PTC presents itself with a tumor localized in the thyroid gland (67%), a mass in the thyroid gland associated with the cervical lymphadenopathy (13%), or only lymphadenopathy (20%). 8 More frequently (90%), at the moment of diagnosis, children have palpable lymph node metastases. Paradoxically, despite these parameters, children have a better prognosis than adults. 1,9,10 In children, thyroid carcinoma manifests itself with a high incidence of cervical lymph node metastases, extrathyroid extent, and metastases, the most common sites of which are the lungs and bones Because of this strange combination of benign prognosis with an aggressive presentation there is not just one choice of treatment. In this work we analyzed the anatomic and clinical presentation as well as therapy and follow-up of 56 young patients 16 years or younger who underwent surgical operations from 1988 to 2001 for thyroid-differentiated carcinoma. MATERIALS AND METHODS In the Department of General Surgery at the University of Studies, Pisa, 56 children 16 years of age or younger with a diagnosis of 1500 Journal of Pediatric Surgery, Vol 39, No 10 (October), 2004: pp

2 THYROID CANCER IN CHILDREN 1501 PTC from April 1988 to December 2001 underwent a surgical operation. Of these 56, 22 (39%) are Belarus children who manifested a thyroid papillary carcinoma after being exposed to ionizing radiation produced from the explosion of the Chernobyl nuclear power plant. Thirty-four (61%) are children who had a thyroid carcinoma but no history of exposure to ionizing radiation. All the children underwent clinical, instrumental, and laboratory examinations. The presurgical examinations carried out were clinical, hematochemical, a complete profile of the thyroid hormones, determinations of the auto-antibodies of the thyroid, an ultrasound scan of the neck, aspiration using a thin needle of the thyroid nodule for a cytologic examination, a laryngoscopy, and a chest radiograph. The De Groot classification 15 was used to determine the stratification of the disease: class 1 tumor limited to the thyroid gland, class 2 metastases in the neck lymph nodes, class 3 tumor invading the thyroid gland, and class 4, distant metastases. Patients with PTC at a low risk of recurrent or persistent disease belong to classes 1 and 2, whereas those of classes 3 and 4 are at a high risk. The children underwent total thyroidectomy or a completion of thyroidectomy after a previous thyroid lobectomy. The time between the first and the second operation was on average 30 months (range, 1 to 6 years). A lymphadenectomy was carried out in patients with evidence of lymph node metastases in the lateral or central compartment regions. A functional modified radical neck dissection was performed to remove all fibrous tissue with lymph nodes, but all motor and sensory nerves as well as the sternocleidomastoid muscle and internal jugular vein were preserved unless invaded by tumor. A postsurgical evaluation was carried out with monitoring of the calcium in the 3 days after the operations, a complete profile of the thyroid hormones, and a laryngoscopy to evaluate recurrent laryngeal nerve function. The follow-up at 5.5 years 41 months was made with laboratory examination: a complete profile of the thyroid hormones (TSH, thyroglobulin), a determination of the autoantibodies of the thyroid (autoantibodies antithyroglobulin), and calcium serum as well as instrumental exams: a thyroid ultrasound scan and a total body scintigraphy. The first follow-up after the surgical treatment was made after about 6 weeks from the operations in a hypothyroid state, using a total body scintigraphy with iodine 131. In the presence of iodium absorbing activity limited to the thyroid bed, a therapeutic dose of about 30 to 50 mci was administered to completely eliminate residual thyroid carcinoma. However, in the case in which the lymph nodes or lungs were involved, a therapeutic dose of about 100 mci was imposed. A total body scintigraphy was repeated after 6 to 12 months from the first, after an appropriate suspension of the thyroid suppression therapy. In the cases in which the disease remained, a new dose of Iodio-radium of about 100 to 150 mci was administered every year. Remission was declared when the patient had a negative total body scintigraphy with immeasurable thyroglobulin levels. When this result was obtained, we began to lengthen the intervals between the scintigraphy examination while continuing to clinically follow-up with the patients and monitoring circulating thyroglobulin. These patients remained off thyroid replacement therapy. Two consecutive negative total body scintigraphies with immeasurable serum thyroglobulin in a hypothyroid state were sufficient evidence of remission to refrain from further routine scintigraphy. The medical therapy consisted of 1-thyroxine to suppress the secretion of endogen TSH and vitamin D and calcium in case of hypocalcemia. A statistical analysis was made on the data comparing the group of the children with radio-induced PTC (RIC) versus non radio-induced PTC (NRIC) using Yates corrected 2 test. RESULTS Of these 56 children, 39 were girls (70%; 14 of 22 RIC versus 25 of 34 NRIC and 17 were boys (30%; 8 of 22 RIC versus 9 of 34 NRIC). The average age at the moment of diagnosis was 11.5 years (9.6 RIC versus 13.4 NRIC) with a range of 4 to 16 years (4 to 14 RIC versus 7 to 16 NRIC). At the moment of diagnosis, 28 patients were in class 1 (50%; 8 of 22 RIC versus 20 of 34 NRIC; P.1712), 24 in class 2 (43%; 12 of 22 RIC versus 12 of 34 NRIC; P.2520), 4 in class 3 (7%; 2 of 22 RIC versus 2 of 34 NRIC), and 0 in class 4 (Table 1). Thirty-seven children (66%) underwent a total thyroidectomy (3 of 22 RIC versus 34 of 34 NRIC), whereas 19 (34%) had a lobectomy followed by a completion of the thyroidectomy (19 of 22 RIC versus 0 of 34 NRIC). Thirty-four (61%) underwent a latero-cervical lymphadenectomy (20 of 22 RIC versus 14 of 34 NRIC; P.0005), of which, 19 cases (56%) were bilateral (3 of 20 RIC versus 6 of 14 NRIC; P.3529), and 15 were monolateral (44%; 7 of 20 RIC versus 8 of 14 NRIC; P.3529); of which, 25 were synchronous tumor (12 of 20 RIC versus 13 of 14 NRIC; P.0814), and 9 were metachronous tumor (8 of 20 RIC versus 1 of 14 NRIC; P.0814; Table 2). Of the 28 cases in class 1, 22 cases (78.5%) underwent Table 1. Clinical and Epidemiologic Data of Children With RIC versus NRIC RIC NRIC P Value* Cases Age (range, 4 to 14) 13.4 (range, 7 to 16) Sex (F/M) 39/17 14/8 25/9 Not significant Histology Papillary 56 Papillary 22 Papillary 34 Multifocal 13 6 (27.3%) 7 (20.6%) Not significant Both lobes 13 6 (27.3%) 7 (20.6%) Not significant Stratification Class (36.4%) 20 (58.8%).1712 Class (54.5%) 12 (35.3%).2520 Class (9.1%) 2 (5.9%) Not significant Class Not significant

3 1502 SPINELLI ET AL Table 2. Surgical Therapy Operation 56 Cases RIC NRIC P Value* Total thyroidectomy 37 (66%) 3 (8%) 34 (92%) Completion of thyroidectomy 19 (34%) 19 (100%) 0 (0%) Latero-cervical lymphadenectomy 34 (61%) 20 (59%) 4 (41%).0005 Bilateral latero-cervical lymphadenectomy 19 (56%) 13 (68%) 6 (32%).3529 Monolateral latero-cervical lymphadenectomy 15 (44%) 7 (47%) 8 (53%).3529 Synchrony latero-cervical lymphadenectomy 25 (73.5%) 12 (48%) 13 (52%).0814 Metachrony latero-cervical lymphadenectomy 9 (26.5%) 8 (89%) 1 (11%).0814 a total thyroidectomy (TT 2 8 RIC versus 20 of 20 NRIC) followed by a second operation of latero-cervical lymphadenectomy in 2 cases (1 of 8 RIC versus 1 of 20 NRIC), the other 6 cases (21.5%) affected by radiation-induced carcinoma underwent, in their own country, a lobectomy (6 of 8 RIC versus 0 of 20 NRIC), and underwent later in Pisa a completion of the thyroidectomy (CT), associated in 5 cases with a latero-cervical lymphadenectomy. Of the 24 cases in class 2, 13 (54%) underwent total thyroidectomy associated with a latero-cervical lymphadenectomy (1 of 12 RIC versus 12 of 12 NRIC), in 2 cases (1 of 12 RIC versus 1 of 12 NRIC), a second surgical operation was necessary owing to residues of neck lymph node metastases. The other 11 cases of class 2 (46%) affected by radiation-induced carcinoma underwent a lobectomy associated with latero-cervical lymphadenectomy in their own country (11 of 12 RIC versus 0 of 12 NRIC), and underwent later in Pisa a completion of thyroidectomy associated in 2 cases with a latero-cervical lymphadenectomy. Of the 4 cases in class 3, 2 (50%) underwent a total thyroidectomy (0 of 2 RIC versus 2 of 2 NRIC), associated in 1 case with a latero-cervical lymphadenectomy, whereas in 2 cases (50%) affected by radiation-induced carcinomas (2 of 2 RIC versus 0 of 2 NRIC, they underwent a lobectomy in their own country followed by a second operation in Pisa, a completion of thyroidectomy associated with a latero-cervical lymphadenectomy. The histologic examination showed a papillary carcinoma in 37 cases of those who underwent a total thyroidectomy (34 NRIC versus 3 RIC). In 19 cases of patients treated with a complete thyroidectomy, a papillary thyroid residual carcinoma in the removed lobe was observed in 3 cases, whereas the lobectomy carried out previously had shown a papillary thyroid cancer in all these patients. In 13 cases (23%) (6 of 22 RIC versus 7 of 34 NRIC), multifocal sites of papillary adenocarcinoma were found throughout the gland; in 13 cases (23%; 6 of 22 RIC versus 7 of 34 NRIC), the carcinoma was seen in both lobes; in 4 cases (7%; 2 of 22 RIC versus 2 of 34 NRIC), the carcinoma presented itself with an extrathyroid infiltration and an invasion of the capsule and vessels. The surgical complications, after the treatment of the 56 children carried out in Pisa, were an acute respiratory insufficiency in 3 cases (5%; 1 of 19 CT versus 2 of 37 TT), which required a temporary tracheotomy, in 4 cases (7%) a permanent hypoparathyroidism (2 of 19 CT versus 2 of 37 TT; P.8755) and in 3 cases (5%) a vocal cord paralysis (2 of 19 CT versus 1 of 37 TT; P.5456; Table 3). In all 56 patients, a follow-up of 5.5 years 41 months was carried out. Currently, of 28 young patients in class 1 26 (93%) are free of disease (6 of 8 RIC versus 20 of 20 NRIC) and 2 (7%) have lung metastases (2 of 8 RIC versus 0 of 20 NRIC) of whom, 1 also has bone metastases (P.1314). Of the 24 cases in class 2, 12 (50%) are currently free of disease (1 of 12 RIC versus 11 of 12 NRIC), 5 (21%) manifest cervical lymph nodal metastases relapses (4 of 12 RIC versus 1 of 12 NRIC) 7 (29%) lung metastases (7 of 12 RIC versus 7 of 12 NRIC), of whom, 5 are associated with cervical lymph nodal metastases relapses (P.0002). Of 4 cases in class 3, 3 (75%) are free of disease (1 of 2 RIC versus 2 of 2 NRIC), and 1 (25%) manifests cervical lymph nodal metastases (1 of 2 RIC versus 0 of 2 NRIC; P.995). On the whole, considering all the children regardless of their initial stratification, 41 (73%) are currently free of disease (8 of 22 RIC versus 33 of 34 NRIC), 1 (2%) manifests cervical lymph nodal metastases (1 of 22 RIC versus 0 of 34 NRIC), 5 (9%) have lymph nodal metastases relapses (4 of 22 RIC versus 1 of 34 NRIC), and 9 Table 3. Postsurgical Complications Cases Completion of Thyroidectomy (19 Cases) Total Thyroidectomy (37 Cases) P Value* Tracheotomy for Acute respiratory insuficience 3 (5.3%) 1 (4.5%) 2 (5.9%) Not significant Permanent hypoparathyroidism 4 (7.1%) 2 (9%) 2 (5.9%).8755 Monolateral vocal cord paralysis 3 (5.3%) 2 (9%) 1 (2.9%).5456

4 THYROID CANCER IN CHILDREN 1503 (16%) have lung metastases (9 of 22 RIC versus 0 of 34 NRIC), of whom, 5 are associated with lymph nodal metastases relapses and 1 with bone metastases (P.0001; Table 4; Fig 1). DISCUSSION The therapeutic strategy of thyroid papillary carcinoma in children is a controversial subject. Experts debate about the most appropriate extent of thyroidectomy, the use of postoperative radioactive iodine ablation, and the need to administer thyroid hormone to suppress the thyroid-stimulating hormone (TSH). 16 The controversy persists because no prospective, randomized, controlled study has evaluated the extent of thyroidectomy, postoperative radioactive iodine therapy, and TSH suppressive therapy. 17 A large multicenter trial with a long follow-up would be required. Generally, 3 surgical approaches have been advocated among experts: thyroid lobectomy or hemithyroidectomy (total removal of one lobe and the isthmus), near-total thyroidectomy (total lobectomy and subtotal resection on the contralateral side to leave 1 g of thyroid tissue), and total thyroidectomy. Some investigators, 13,18,19 believing in the good prognosis of this tumor, consider that the best therapeutic approach is nonextended surgery (thyroid lobectomy or hemithyroidectomy). The most important clinical reasons for carrying out a lobectomy or hemithyroidectomy in children with PTC instead of a thyroidectomy is that the mortality rate does not appear to change significantly in either type of treatment, and the incidence of postoperative complications is minor. Other investigators claim that the safest and most effective primary treatment for thyroid carcinoma in children is total thyroidectomy. Multivariate analysis in large retrospective studies both in children and adults, have reported higher recurrence and mortality rates in those patients who have undergone procedures less than total thyroidectomy. 15,25-27 Fig 1. Postsurgical follow-up. An age inferior to or equal to 16 years and a major surgical extent seem to be directly correlated with the increase in morbidity. 12,13 In particular, from our data we have seen 3 cases (5.3%) of acute respiratory insufficiency that required temporary tracheotomy for bilateral hypomobility of the vocal cords of a transitory type, 3 cases (5.3%) of monolateral paralysis of a vocal cord, and 4 cases (7.5%) of permanent hypoparathyroidism. Complications were significantly higher in the group of children who underwent a completion of thyroidectomy compared with those who underwent only total thyroidectomy (P.5). Recurrent laryngeal nerve injury is particularly high in thyroid surgery in children with a percentage that ranges from 0.5% to 30%. 13,28,29 This complication occurs more often in operations for carcinomas of great extent, in particular, thyroid carcinomas with extrathyroid extent and lymph node metastases. 28 Children are at major risk of both temporary and permanent postoperative hypocalcemy compared with adults. The greater the extent of Table 4. Postsurgical Follow-Up Cases RIC NRIC P Value* Class 1 28 (50%) (75%) Free 20 (100%) Free (25%) Recurrence Class 2 24 (43%) (8.3%) Free 11 (91.7%) Free (91.7%) Recurrence 1 (8.3%) Recurrence Class 3 4 (7%) (50%) Free 2 (100%) Free Not significant (.995) 1 (50%) Recurrence Total (36.4%) Free 33 (97.1%) Free (63.6%) Recurrence 1 (2.9%) Recurrence

5 1504 SPINELLI ET AL surgical excision the higher the risk of hypocalcemia with a percentage that ranges from 8% to 24%. 12,16 Although advocates of lesser procedures contend that the risk of complications is higher after total thyroidectomy, numerous surgeons experienced in performing total thyroidectomy report lower complication rates than the rates reported by some surgeons performing lesser procedures. 30 Total thyroidectomy for thyroid-differentiated carcinoma has some advantages. (1) The thyroglobulin (Tg) dosage is more useful as a marker of relapses when all the thyroid tissue has been removed. After total thyroidectomy, an elevated Tg level ( 3 mg/dl) in patients with PTC indicates either normal residual thyroid tissue or persistent of recurrent thyroid cancer. Using serum Tg levels to follow-up with patients with PTC can reduce the need for frequent radioactive iodine scanning. 31,32 (2) A total thyroidectomy removes all primitive tumor sites and also multiple tumor foci and the potential residual cancer that could remain in the contralateral lobe. In the literature, the multifocality and the presence of cancer in both lobes recurs with high frequency both in pediatric and adult patients, respectively, in 50% to 80% 16,22,33 and 30% to 61%. 13,16,20,34 In our data, in the cases of completion of thyroidectomy, we have observed that 3 of 19 (16%) presented thyroid papillary carcinoma residues in the remaining lobe after lobectomy that had not been diagnosed previously. (3) The removal of all the thyroid gland excludes the possibility of the papillary cancer residues transforming into a nondifferentiated type, anaplastic (1%), which is uniformly lethal. 35,36 (4) There is the possibility of effectively treating thyroid-differentiated cancer metastases with radioactive iodine therapy, as the incidence of distant metastases is high, especially in the lungs in these children. 28,37,38 (5) There is the possibility of finding hidden metastases, especially in the lungs, with total body scintigraphy, which can be carried out only after total thyroidectomy. These are difficult to see with a lung radiography, whereas they are identified easily with a scintigraphy. 1,28 So, without the help of total body scintigraphy in the postsurgical follow-up, these are diagnosed only later so as to require a higher dose of I 131 with a higher risk of collateral effects. 39 In our data, we have a high incidence of lung metastases (9 of 22; 41%) diagnosed with total body scintigraphy, especially in children with RIC. The percentage reaches up to 63.6% if we include the cervical lymph nodes and bone metastases diagnosed with scintigraphy in addition to the lung lesions. The postsurgical follow-up has shown a mortality rate of 0% and a recurrent rate of 33.5% (64% radiation-induced carcinoma versus 3% non radiationinduced carcinoma), thus, underlining a different biological behavior between the induced carcinomas by ionizing radiations versus non radio-induced forms. In the first group, we observed a diagnosis of the disease at a much earlier age in a more advanced stage and a higher recurrence of disease with metastases of the cervical lymph nodes and distant metastases. Although many of these patients present a relapse of the disease, the percentage of global survival is excellent in both groups. It was observed that in 70% of Belarus children with radio-induced thyroid papillary carcinoma present with a mutation of proto-oncogene RET, specific and exclusive for this hystologic type of tumor, PTC (papillary thyroid carcinoma). 40 Such a high percentage has not been found in adult patients in any geographical area. This makes us suppose that the activation of RET is typical of infantile papillary carcinoma or more likely is specifically associated with papillary carcinoma induced by radiation. 41,42 At an experimental level in the transgenic mouse model, we observed that the presence of RET/PTC3 is associated with an aggressive form with a high tendency for metastases of the regional lymph nodes and those at distance (lungs). 42 Probably also the different choice of surgical therapy in both groups of our study may have influenced the prognosis of patients with radiation-induced carcinoma. The radiation-induced papillary carcinoma was treated with a surgical strategy in 2 stages. The first step was lobectomy followed by a completion of thyroidectomy, with an average interval between the 2 surgical operations of 30 months (1 to 6 years), whereas a single-phase, total thyroidectomy from the start was carried out in the non radiation-induced carcinoma patients. The surgical treatment that we recommend is a total thyroidectomy in a single step both for children affected by radiation-induced and non radiation-induced papillary thyroid carcinoma. 1. Bal CS, Padhy AK, Kumar A: Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub- Himalayan iodine-deficient endemic zone. Nucl Med Commun 22: , Fassina AS, Rupolo M, Pelizzo MR: Thyroid cancer in children and adolescents. Tumori 80: , Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, CA Cancer J Clin 50:7-33, Zafra Anta MA, Amor Cabrera MA, Diaz Mier F, et al: Effects on REFERENCES health due to the Chernobyl disaster. Fifteen years after. An Esp Pediatr 56: , Hoshi M, Konstantinov YO, Evdeeva TY, et al: Radiocesium in children residing in the western districts of the Bryansk oblast from Health Phys 79: , Baverstock K, Egloff B, Pinchera A, et al: Thyroid cancer after Chernobyl. Nature 359:21-22, Williams ED: Fallout from Chernobyl. Thyroid cancer in children

6 THYROID CANCER IN CHILDREN 1505 increased dramatically in Belarus. BMJ 309:1298discussion 1300 (letter; comment), Carcangiu ML, Zampi G, Pupi A, et al: Papillary carcinoma of the thyroid: A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805, Rosen IB, Bowden J, Luk SC, et al: Aggressive thyroid cancer in low risk age population. Surgery 102: , Cody B, Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: , Gorlin JB, Sallan SE: Thyroid cancer in childhood. Endocrinol Metab Clin North Am 19:649, Zimmerman D, Hay ID, Gough IR, et al: Papillary thyroid cancer in children and adults: Long term follow up of 1039 patients conservatively treated at one institution in three decades. Surgery 104: , La Quaglia MP, Corbally MT, Heller G, et al: Recurrence and morbidity in differentiated thyroid carcinoma in children. Surgery 104: , Mishra A, Mishra SK, Agarwal A: Metastatic differentiated thyroid carcinoma: Clinicopathological profile and outcome in an iodine deficient area. World J Surg 26: , De Groot LS, Kaplan EL, McCormick M, et al: Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414, Grigsby PW, Gal-or A, Michalski JM, et al: Childhood and adolescent thyroid carcinoma. Cancer 95: , La Quaglia MP, Black T, Holcomb GW 3rd, et al: Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who presented with distant metastases. A report from the surgical discipline committee of the children s cancer group. J Pediatr Surg 35: , Tallroth E, Backdahl M, Einhorn J, et al: Thyroid carcinoma in children and adolescents. Cancer 58: , Hay ID, Grant CS, Bergstrahl EJ, et al: Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AM low-risk papillary thyroid carcinoma? Surgery 124: , Miccoli P, Antonelli A, Spinelli C: Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident. Arch Surg 133:89-93, Harness JA, Thompson NW, McLeod MK, et al: Differentiated thyroid carcinoma in children and adolescents. World J Surg 16: , Mazzaferri EL: Long-term outcome of patients with differentiated thyroid carcinoma: Effect of therapy. Endocr Pract 6: , Mazzaferri EL, Kloos RT: Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86: , Jocham A, Joppich I, Hecker W, et al: Thyroid carcinoma in childhood: Management and follow-up of 11 cases. Eur J Pediatr 153:17-22, Mazzaferri EL, Jhiang SM: Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: , Loh KC, Greenspan FS, Gee L, et al: Pathologic tumor-nodemetastase (ptnm) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients. J Clin Endocrinol Metab 97:3553, Hay Ian D, Thompson GB, Grant CS, et al: Papillary thyroid carcinoma managed at the Mayo Clinic during six decades ( ): Temporal trends in initial therapy and long- term outcome in 2444 consecutively treated patients. World J Surg 26: , Ceccarelli C, Pacini F, Lippi F, et al: Thyroid cancer in children and adolescents. Surgery 104: , Harris SC: Thyroid and parathyroid surgical complications. Am J Surg 163:476, Jossart G, Clark OH: Well-differentiated thyroid cancer. Clin Probl Surg 31:939, Girelli ME, Busnardo B, Amerio R, et al: Serum thyroglobulin level in patients with well-differentiated thyroid cancer during suppression therapy: Study on 429 patients. Eur J Nucl Med 10:252, Clark OH, Hoelting T: Management of patients with differentiated thyroid cancer who have positive serum thyroglobuline levels and negative radioiodine scans. Thyroid 4:501, Thyroid gland, in American Joint Committee on Cancer: AJCC Cancer Staging Manual (eds). Philadelphia, PA, Lippincott-Raven Publishers, 1997, pp Segal K, Hadar T, Lubin E, et al: Thyroid carcinoma in children and adolescents. Harefuah 122:83-86, Allo MD, Christianson W, Koivunen D: Not all papillary carcinomas are minimal. Surgery 102:1075, Ward PH: The surgical treatment of thyroid cancer. Arch Otolaryngol Head Neck Surg 112:1204, Weinberg AD, Kripalani S, McCarthy PL, et al: Caring for survivors of the Chernobyl disaster. What the clinician should know. JAMA 274: , Schlumberger M, De Vathaire F, Travagli JP, et al: Differentiated thyroid carcinoma in childhood: Long term follow-up in 72 patients. J Clin Endocrinol Metab 65: , Reeve T, Thompson NW: Complications of thyroid surgery: How to avoid them, how to manage them, and observations on their possible effect on the whole patient. World J Surg 24: , Klugbauer S, Jauch A, Lengfelder E, et al: A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8). Cancer Res 60: , Pacini F, Vorontsova T, Molinaro E, et al: Thyroid consequences of the Chernobyl nuclear accident. Acta Pediatr 88(Suppl):23-27, Thomas GA, Bunnell H, Cook HA, et al: High prevalence of RET/PTC rearrangements in Ukrainian and Bielorussian post-chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84: , 1999

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine THYROID CANCER IN CHILDREN Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine Thyroid nodules Rare Female predominance 4-fold as likely to be malignant Hx Radiation exposure?

More information

Childhood and Adolescent Thyroid Carcinoma

Childhood and Adolescent Thyroid Carcinoma 724 Childhood and Adolescent Thyroid Carcinoma Perry W. Grigsby, M.D. 1 Anat Gal-or, B.Sc. 1 Jeff M. Michalski, M.D. 2 Gerard M. Doherty, M.D. 2 1 Department of Radiation Oncology, Mallinckrodt Institute

More information

Persistent & Recurrent Differentiated Thyroid Cancer

Persistent & Recurrent Differentiated Thyroid Cancer Persistent & Recurrent Differentiated Thyroid Cancer Electron Kebebew University of California, San Francisco Department of Surgery Objectives Risk factors for persistent & recurrent disease Causes of

More information

THYROID CANCER IN CHILDREN

THYROID CANCER IN CHILDREN THYROID CANCER IN CHILDREN Isabel ROCA, Montserrat NEGRE Joan CASTELL HU VALL HEBRON BARCELONA EPIDEMIOLOGY ADULTS males 1,2-2,6 cases /100.000 females 2,0-3,8 cases /100.000 0,02-0,3 / 100.000 children

More information

ORIGINAL ARTICLE. Completion Total Thyroidectomy in Children With Thyroid Cancer Secondary to the Chernobyl Accident

ORIGINAL ARTICLE. Completion Total Thyroidectomy in Children With Thyroid Cancer Secondary to the Chernobyl Accident ORIGINAL ARTICLE Completion in Children With Thyroid Cancer Secondary to the Chernobyl Accident Paolo Miccoli, MD; Alessandro Antonelli, MD; Claudio Spinelli, MD; Marco Ferdeghini, MD; Poupak Fallahi,

More information

PEDIATRIC Ariel Katz MD

PEDIATRIC Ariel Katz MD PEDIATRIC Ariel Katz MD Dept. Otolaryngology Head &Neck Surgery Wolfson Medical Center Holon, Israel OBJECTIVES Overview/Background Epidemiology/Etiology Intro to Guidelines Workup Treatment Follow-Up

More information

Reoperative central neck surgery

Reoperative central neck surgery Reoperative central neck surgery R. Pandev, I. Tersiev, M. Belitova, A. Kouizi, D. Damyanov University Clinic of Surgery, Section Endocrine Surgery University Hospital Queen Johanna ISUL Medical University

More information

Differentiated Thyroid Cancer: Initial Management

Differentiated Thyroid Cancer: Initial Management Page 1 ATA HOME GIVE ONLINE ABOUT THE ATA JOIN THE ATA MEMBER SIGN-IN INFORMATION FOR PATIENTS FIND A THYROID SPECIALIST Home Management Guidelines for Patients with Thyroid Nodules and Differentiated

More information

Gerard M. Doherty, MD

Gerard M. Doherty, MD Surgical Management of Differentiated Thyroid Cancer: Update on 2015 ATA Guidelines Gerard M. Doherty, MD Chair of Surgery Utley Professor of Surgery and Medicine Boston University Surgeon-in-Chief Boston

More information

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose. Thyroid Nodule Evaluating the patient with a thyroid nodule and some management options. Miguel V. Valdez PA C Disclosure Nothing to disclose. Learning Objectives Examination of thyroid gland Options for

More information

Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update

Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update Bangladesh J Otorhinolaryngol 2010; 16(2): 126-130 Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update Md. Abdul Mobin Choudhury 1, Md. Abdul Alim Shaikh

More information

10/24/2008. Surgery for Well-differentiated Thyroid Carcinoma- The Primary

10/24/2008. Surgery for Well-differentiated Thyroid Carcinoma- The Primary Surgery for Well-differentiated Thyroid Carcinoma- The Primary Head and Neck Endocrine Surgery Department of Otolaryngology-Head and Neck Surgery, UCSF October 24-25, 2008 Robert A. Sofferman, MD Professor

More information

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study ORIGINAL ARTICLE A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study Joon-Hyop Lee, MD, Yoo Seung Chung, MD, PhD,* Young Don Lee, MD, PhD

More information

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey. Management of Differentiated Thyroid Cancer: Head Neck Surgeon Perspective Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey Thyroid gland Small endocrine gland:

More information

RESEARCH ARTICLE. Comparison of Presentation and Clinical Outcome between Children and Young Adults with Differentiated Thyroid Cancer

RESEARCH ARTICLE. Comparison of Presentation and Clinical Outcome between Children and Young Adults with Differentiated Thyroid Cancer RESEARCH ARTICLE Comparison of Presentation and Clinical Outcome between Children and Young Adults with Jian-Tao Wang 1,2&, Rui Huang 1&, An-Ren Kuang 1 * Abstract Background: The aim of the present study

More information

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Its Not Just About the Nodes AACE Advances in Medical and Surgical Management of Thyroid Cancer - 2017 Robert A. Levine, MD,

More information

Thyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA

Thyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA Thyroid Nodules ENDOCRINOLOGY DIVISION ENDOCRINOLOGY DIVISION Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA Anatomical Considerations The Thyroid Nodule Congenital anomalies Thyroglossal

More information

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies

More information

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines 2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines Angela M. Leung, MD, MSc, ECNU November 5, 2016 Outline Workup of nontoxic thyroid nodule(s) Ultrasound FNAB Management of FNAB results

More information

Introduction. Materials and methods Y-N XU 1,2, J-D WANG 1,2

Introduction. Materials and methods Y-N XU 1,2, J-D WANG 1,2 1 di 5 11/04/2016 17:54 G Chir Vol. 31 - n. 5 - pp. 205-209 Maggio 2010 Y-N XU 1,2, J-D WANG 1,2 Introduction The World Health Organization (WHO) defined papillary thyroid microcarcinomas (PTMC) as tumors

More information

SARDA AND OTHERS No. of patients (%) Figure 1. Age distribution. Papillary Follicular < > 60 Age at chagnos

SARDA AND OTHERS No. of patients (%) Figure 1. Age distribution. Papillary Follicular < > 60 Age at chagnos Asian Journal of Surgery Excerpta Medica Asia Ltd Prognostic Factors for Well-Differentiated Thyroid Cancer in an Endemic Area A.K. Sarda, Shweta Aggarwal, Durgatosh Pandey, Gagan Gautam, Department of

More information

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF MICHIGAN MICHIGAN AACE 2018 ANNUAL MEETING Thyroid Cancer: When Not to Treat? FOCUS WILL BE ON LOW-RISK

More information

- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer

- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer Thyroid Cancer UpToDate: Introduction: Risk Factors: Biology: Symptoms: Diagnosis: 1. Lenvina is the first line therapy with powerful durable response and superior PFS in pts with RAI-refractory disease.

More information

PAPER. Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma

PAPER. Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma PAPER Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma Sendia Kim, MD; John P. Wei, MD; Joshua M. Braveman, MD; David M. Brams, MD Hypothesis: The prognosis of papillary thyroid

More information

Calcitonin. 1

Calcitonin.  1 Calcitonin Medullary thyroid carcinoma (MTC) is characterized by a high concentration of serum calcitonin. Routine measurement of serum calcitonin concentration has been advocated for detection of MTC

More information

Adjuvant therapy for thyroid cancer

Adjuvant therapy for thyroid cancer Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women

More information

How good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status

How good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status New Perspectives in Thyroid Cancer Jennifer Sipos, MD Assistant Professor of Medicine Division of Endocrinology The Ohio State University Outline Thyroid Nodules Thyroid Cancer Epidemiology Initial management

More information

Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries

Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries REVIEW ARTICLE J Korean Thyroid Assoc Vol. 4, No. 2, November 2011 Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries Yasuhiro Ito, MD and Akira Miyauchi, MD

More information

Management of Thyroid Nodules

Management of Thyroid Nodules Management of Thyroid Nodules 38 y/o female with solid 1.5 cm right Thyroid nodule. TSH=0.68 Vincent J. Reid, MD., FACS Thyroid Cancer Incidence & Mortality 1974 to 2004 Overall Women Men Mortality 1 Cancer

More information

I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER

I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS Advances in Medical and Surgical Management of Thyroid Cancer January 23-24, 2015 I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER 2015 Leonard Wartofsky,

More information

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer AACE - Advances in Medical and Surgical Management of Thyroid Cancer - 2018 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel

More information

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women Thyroid cancer- what s new Thyroid Cancer Changing epidemiology Molecular markers Lymph node dissection Technical advances rhtsh Genetic testing and prophylactic surgery Vandetanib What s new? Jessica

More information

Differentiated Thyroid Carcinoma

Differentiated Thyroid Carcinoma Differentiated Thyroid Carcinoma The GOOD cancer? Jennifer Sipos, MD Associate Professor of Medicine Director, Benign Thyroid Program Division of Endocrinology, Diabetes and Metabolism The Ohio State University

More information

Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study

Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study ONCOLOGY LETTERS 10: 1749-1754, 2015 Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study SHANGTONG LEI 1, ZIHAI

More information

T here are four parathyroid glands, which are located

T here are four parathyroid glands, which are located 245 ORIGINAL ARTICLE Parathyroid invasion, nodal recurrence, and lung metastasis by papillary carcinoma of the thyroid K Kakudo, W Tang, Y Ito, Y Nakamura, H Yasuoka, S Morita, A Miyauchi... See end of

More information

Thyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary

Thyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary Thyroid nodules - medical and surgical management JRE Davis NR Parrott Endocrinology and Endocrine Surgery Manchester Royal Infirmary Thyroid nodules - prevalence Thyroid nodules common, increase with

More information

Pediatric Thyroid Cancer Lung Metastases. Liora Lazar MD

Pediatric Thyroid Cancer Lung Metastases. Liora Lazar MD Pediatric Thyroid Cancer Lung Metastases Liora Lazar MD Differentiated thyroid cancer (DTC) The 3rd most common solid tumor in childhood and adolescence Accounting for 1.5%-3% of all childhood cancers

More information

Review Article Management of thyroid carcinoma Alauddin M, Joarder AH

Review Article Management of thyroid carcinoma Alauddin M, Joarder AH Management of thyroid carcinoma Alauddin M, Joarder AH The ORION Medical Journal 2004 May;18:163-166 Overview The two most common forms of thyroid cancer, papillaryand follicular thyroid cancer, together

More information

Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting?

Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting? Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting? Jacob Moalem, MD, FACS Associate Professor Endocrine Surgery and Endocrinology URMC Agenda 1. When is lobectomy alone

More information

Management guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007

Management guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007 Management guideline for patients with differentiated thyroid Teeraporn Ratanaanekchai ENT, KKU 17 October 2007 Incidence (Srinagarind Hospital, 2005, both sex) Site (all) cases % 1. Liver 1178 27 2. Lung

More information

ORIGINAL ARTICLE. Influence of Previous Radiation Exposure on Pathologic Features and Clinical Outcome in Patients With Thyroid Cancer

ORIGINAL ARTICLE. Influence of Previous Radiation Exposure on Pathologic Features and Clinical Outcome in Patients With Thyroid Cancer ORIGINAL ARTICLE Influence of Previous Radiation Exposure on Pathologic Features and Clinical Outcome in Patients With Thyroid Cancer Raewyn M. Seaberg, MD, PhD; Spiro Eski, MD; Jeremy L. Freeman, MD,

More information

What you need to know about Thyroid Cancer

What you need to know about Thyroid Cancer What you need to know about Thyroid Cancer This booklet has been designed to help you to learn more about your thyroid cancer. It covers the most important areas and answers some of the frequently asked

More information

Original Article. Adolescents Who Underwent Thyroid Surgeries for Thyroid Cancers and Masses. Z TÜRKYILMAZ, R KARABULUT, K SöNMEZ, AC BA AKLAR

Original Article. Adolescents Who Underwent Thyroid Surgeries for Thyroid Cancers and Masses. Z TÜRKYILMAZ, R KARABULUT, K SöNMEZ, AC BA AKLAR HK J Paediatr (new series) 2017;22:137-143 Original Article Adolescents Who Underwent Thyroid Surgeries for Thyroid Cancers and Masses Z TÜRKYILMAZ, R KARABULUT, K SöNMEZ, AC BA AKLAR Abstract Objective:

More information

Current Issues in Thyroid Cancer Surgery in 2017

Current Issues in Thyroid Cancer Surgery in 2017 Current Issues in Thyroid Cancer Surgery in 2017 Dr. David Goldstein MD Msc FRCSC FACS Associate Professor, Department Otolaryngology Head & Neck Surgery, U of T Department of Surgical Oncology, Princess

More information

Mandana Moosavi 1 and Stuart Kreisman Background

Mandana Moosavi 1 and Stuart Kreisman Background Case Reports in Endocrinology Volume 2016, Article ID 6471081, 4 pages http://dx.doi.org/10.1155/2016/6471081 Case Report A Case Report of Dramatically Increased Thyroglobulin after Lymph Node Biopsy in

More information

ORIGINAL ARTICLE. Management and Outcome of Recurrent Well-Differentiated Thyroid Carcinoma

ORIGINAL ARTICLE. Management and Outcome of Recurrent Well-Differentiated Thyroid Carcinoma ORIGINAL ARTICLE Management and Outcome of Recurrent Well-Differentiated Thyroid Carcinoma Carsten E. Palme, MBBS, FRACS; Zeeshan Waseem, BA; S. Naweed Raza, BSc; Spiro Eski, MD; Paul Walfish, MD, FRCPC;

More information

Dr J K Jekel Dept. Surgery University of Pretoria

Dr J K Jekel Dept. Surgery University of Pretoria Dr J K Jekel Dept. Surgery University of Pretoria No Maybe ( T`s and C`s apply ) 1. Total thyroidectomy 2. Neck dissection only if nodes are involved 3. Ablative dose or doses of Radioactive Iodine 4.

More information

Management of Recurrent Thyroid Cancer

Management of Recurrent Thyroid Cancer Management of Recurrent Thyroid Cancer Eric Genden, MD, MHA Isidore Professor and Chairman Department of Otolaryngology- Head and Neck Surgery Senior Associate Dean for Clinical Affairs The Icahn School

More information

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans 131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans Anca M. Avram, M.D. Associate Professor of Radiology Department of Nuclear Medicine University of Michigan Ann Arbor,

More information

Papillary Thyroid Microcarcinoma Presenting as Horner s Syndrome: A Novel Clinical Presentation

Papillary Thyroid Microcarcinoma Presenting as Horner s Syndrome: A Novel Clinical Presentation Case Report American Journal of Cancer Case Reports http://ivyunion.org/index.php/ajccr/ Page 1 of 6 Papillary Thyroid Microcarcinoma Presenting as Horner s Syndrome: A Novel Clinical Presentation Ammara

More information

WTC 2013 Panel Discussion: Minimal disease

WTC 2013 Panel Discussion: Minimal disease WTC 2013 Panel Discussion: Minimal disease Susan J. Mandel MD MPH Panelists Ken Ain Yasuhiro Ito Stephanie Lee Erich Sturgis Mark Urken Faculty/Presenter Disclosure Relationships with commercial interests

More information

ORIGINAL ARTICLE. Changing Trends and Prognoses for Patients With Papillary Thyroid Cancer

ORIGINAL ARTICLE. Changing Trends and Prognoses for Patients With Papillary Thyroid Cancer ORIGINAL ARTICLE Changing Trends and Prognoses for Patients With Papillary Thyroid Cancer Hiroyuki Yamashita, MD, PhD; Shiro Noguchi, MD, PhD; Hiroto Yamashita, MD, PhD; Nobuo Murakami, MD; Shin Watanabe,

More information

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA

More information

Incidental versus clinically evident thyroid cancer: A 5-year follow-up study

Incidental versus clinically evident thyroid cancer: A 5-year follow-up study ORIGINAL ARTICLE Incidental versus clinically evident : A 5-year follow-up study Michele N. Minuto, MD, PhD, 1 * Mario Miccoli, DStat, 2 David Viola, MD, 3 Clara Ugolini, MD, PhD, 1 Riccardo Giannini,

More information

ORIGINAL ARTICLE. Indications for Bilateral Modified Radical Neck Dissection in Patients With Papillary Carcinoma of the Thyroid

ORIGINAL ARTICLE. Indications for Bilateral Modified Radical Neck Dissection in Patients With Papillary Carcinoma of the Thyroid ORIGINAL ARTICLE Indications for Bilateral Modified Radical Neck Dissection in Patients With Papillary Carcinoma of the Thyroid Akira Ohshima, MD, PhD; Hiroyuki Yamashita, MD, PhD; Shiro Noguchi, MD, PhD;

More information

Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler, MD, Roee Landsberg, MD, Dan M. Fliss, MD

Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler, MD, Roee Landsberg, MD, Dan M. Fliss, MD ORIGINAL ARTICLE ELECTIVE PARATRACHEAL NECK DISSECTION FOR LATERAL METASTASES FROM PAPILLARY CARCINOMA OF THE THYROID: IS IT INDICATED? Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler,

More information

Changing trends in the management of well-differentiated thyroid carcinoma in Korea

Changing trends in the management of well-differentiated thyroid carcinoma in Korea 2016, 63 (6), 515-521 Original Changing trends in the management of well-differentiated thyroid carcinoma in Korea Yong Sang Lee, Hang-Seok Chang and Cheong Soo Park Thyroid Cancer Center, Department of

More information

Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients

Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients ORIGINAL ARTICLE Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients Jianbiao Wang, MM, 1 Haili Sun, BM,

More information

A Review of Differentiated Thyroid Cancer

A Review of Differentiated Thyroid Cancer A Review of Differentiated Thyroid Cancer April 21 st, 2016 FPON Webcast Jonn Wu BMSc MD FRCPC Radiation Oncologist, Vancouver Centre Chair, Provincial H&N Tumour Group, BCCA Clinical Associate Professor,

More information

/.5]: (043.3) (476)

/.5]: (043.3) (476) ..» 616.441-006.6-089-053.2/.5]:616-07-08-037(043.3) (476) :,, 14.01.12 -, 2014 1 » : : :,,,,,,, «-..»,,,,,, «-» «4» 2015. 14. 03.12.01 «..» (223040,,., e-mail: NArtemova@omr.med.by,. +375172879561). «..»

More information

Evaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada

Evaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada Evaluation and Management of Thyroid Nodules Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada Disclosure Consulting Amgen Speaking Amgen Objectives Understand the significance of incidental

More information

Case Scenario 1: Thyroid

Case Scenario 1: Thyroid Case Scenario 1: Thyroid History and Physical Patient is an otherwise healthy 80 year old female with the complaint of a neck mass first noticed two weeks ago. The mass has increased in size and is palpable.

More information

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50% Pinhole images of the neck are acquired in multiple projections, 24hrs after the oral administration of approximately 200 µci of I123. Usually, 24hr uptake value if also calculated (normal 24 hr uptake

More information

Operative bed recurrence of thyroid cancer: utility of a preoperative needle localization technique

Operative bed recurrence of thyroid cancer: utility of a preoperative needle localization technique Original Article Operative bed recurrence of thyroid cancer: utility of a preoperative needle localization technique Oliver S. Eng 1, Scott B. Grant 2, Jason Weissler 3, Mitchell Simon 4, Sudipta Roychowdhury

More information

Thyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma.

Thyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma. ORIGINAL ARTICLE Thyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma. Md. Sayedur Rahman Miah, Md. Reajul Islam, Tanjim Siddika Institute of Nuclear Medicine & Allied Sciences,

More information

Radioactivity and thyroid cancer *

Radioactivity and thyroid cancer * HORMONES 2009, 8(3):185-191 Review Radioactivity and thyroid cancer * Christopher Reiners Clinic and Polyclinic of Nuclear Medicine University of Würzburg ABSTRACT There is no evidence that natural radiation

More information

Differentiated Thyroid Carcinoma: The Impact of Initial Surgical Therapy

Differentiated Thyroid Carcinoma: The Impact of Initial Surgical Therapy CLINICAL STUDY Differentiated Thyroid Carcinoma: The Impact of Initial Surgical Therapy Dr. Gamal A. Khairy FRCS, FBS, MS Associate Professor of Surgery and Consultant Surgeon College of Medicine, King

More information

Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer

Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer DEBATE WJOES Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer Ashok R Shaha

More information

Chapter 14: Thyroid Cancer

Chapter 14: Thyroid Cancer The American Academy of Otolaryngology Head and Neck Surgery Foundation (AAO-HNSF) Presents... Chapter 14: Thyroid Cancer Daiichi Pharmaceutical Corporation, marketers and distributors of FLOXIN Otic (ofloxacin

More information

Prognostic factors in patients with welldifferentiated pulmonary metastasis

Prognostic factors in patients with welldifferentiated pulmonary metastasis Washington University School of Medicine Digital Commons@Becker Open Access Publications 2008 Prognostic factors in patients with welldifferentiated thyroid cancer presenting with pulmonary metastasis

More information

Role of Radio-Iodine Ablation According to Risk Stratification in Well Differentiated Thyroid Cancer

Role of Radio-Iodine Ablation According to Risk Stratification in Well Differentiated Thyroid Cancer Journal of the Egyptian Nat. Cancer Inst., Vol. 13, No. 1, March: 6369, 2001 Role of RadioIodine Ablation According to Risk Stratification in Well Differentiated Thyroid Cancer HOSNA MOUSTAFA, M.D.*; SHEREEN

More information

Case 5: Thyroid cancer in 42 yr-old woman with Graves disease

Case 5: Thyroid cancer in 42 yr-old woman with Graves disease Case 5: Thyroid cancer in 42 yr-old woman with Graves disease Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Thyroid cancer in 42 yr-old woman with

More information

Research Article Papillary Thyroid Cancer, Macrofollicular Variant: The Follow-Up and Analysis of Prognosis of 5 Patients

Research Article Papillary Thyroid Cancer, Macrofollicular Variant: The Follow-Up and Analysis of Prognosis of 5 Patients yroid Research, Article ID 818134, 4 pages http://dx.doi.org/10.1155/2014/818134 Research Article Papillary Thyroid Cancer, Macrofollicular Variant: The Follow-Up and Analysis of Prognosis of 5 Patients

More information

Prognostic Factors for Well Differentiated Thyroid Cancer in an Endemic Area

Prognostic Factors for Well Differentiated Thyroid Cancer in an Endemic Area Prognostic Factors for Well Differentiated Thyroid Cancer in an Endemic Area A retrospective analysis of 215 differentiated thyroid cancers was undertaken to identify the various prognostic variables.

More information

RESEARCH ARTICLE. Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131 I Ablation Therapy for Differentiated Thyroid Cancer

RESEARCH ARTICLE. Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131 I Ablation Therapy for Differentiated Thyroid Cancer RESEARCH ARTICLE Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131 I Ablation Therapy for Differentiated Thyroid Cancer Zekiye Hasbek 1 *, Bulent Turgut 1, Fatih Kilicli 2,

More information

Thyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis

Thyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis Most thyroid nodules are benign Thyroid nodules Postgraduate Course in General Surgery thyroid nodules occur in 77% of the world s population palpable thyroid nodules occur in about 5% of women and 1%

More information

Preoperative Evaluation

Preoperative Evaluation Preoperative Evaluation Lateral compartment lymph nodes are easier to detect and are amenable to FNA Central compartment lymph nodes are much more difficult to detect and FNA (Tg washout testing is compromised)

More information

Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer

Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer A rational approach to longterm follow-up based on dynamic risk assessment. World Congress on Thyroid

More information

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES AJC 7/14/06 1:19 PM Page 67 Thyroid C73.9 Thyroid gland SUMMARY OF CHANGES Tumor staging (T) has been revised and the categories redefined. T4 is now divided into T4a and T4b. Nodal staging (N) has been

More information

Risk Adapted Follow-Up

Risk Adapted Follow-Up Risk Adapted Follow-Up Individualizing Follow- Up Strategies R Michael Tuttle, MD Clinical Director, Endocrinology Service Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Medical College

More information

Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence.

Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence. Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence.

More information

B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.

B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b. Deficiency of dietary iodine: - Is linked with a

More information

Thyroid Gland. Protocol applies to all malignant tumors of the thyroid gland, except lymphomas.

Thyroid Gland. Protocol applies to all malignant tumors of the thyroid gland, except lymphomas. Thyroid Gland Protocol applies to all malignant tumors of the thyroid gland, except lymphomas. Procedures Cytology (No Accompanying Checklist) Partial Thyroidectomy Total Thyroidectomy With/Without Lymph

More information

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release 2 REVISION HISTORY Date Author / Editor Comments 5/19/2014 Jaleh Mirza Created the document 8/12/2014 Samantha Spencer/Jaleh

More information

To the Patient and Family This booklet has been written for people who have received a diagnosis of thyroid cancer or who are being tested for this illness. If you have questions that are not answered

More information

Diagnostic 131 I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer

Diagnostic 131 I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer European Journal of Endocrinology (2004) 150 649 653 ISSN 0804-4643 CLINICAL STUDY Diagnostic 131 I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer Henry Taylor,

More information

Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events

Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events Sandrine Rorive, M.D., PhD. Erasme Hospital - Université Libre de Bruxelles (ULB) INTRODUCTION The assessment of thyroid nodules

More information

Thyroid Cancer: Overview And Peculiar Aspects In Philippines Nemencio A. Nicodemus Jr., MD

Thyroid Cancer: Overview And Peculiar Aspects In Philippines Nemencio A. Nicodemus Jr., MD 16 April 2016, Manila, Philippines Thyroid Cancer: Overview And Peculiar Aspects In Philippines Nemencio A. Nicodemus Jr., MD IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Learning

More information

Prognostic Evaluation of Patients With Multicentric Papillary Thyroid Microcarcinoma

Prognostic Evaluation of Patients With Multicentric Papillary Thyroid Microcarcinoma Volume 110 Number 8 August 2011 Formosan Medical Association Taipei, Taiwan ISSN 0929 6646 Resveratrol for prophylaxis of ischemic stroke Microglia and chronic pain ART in HIV-1-discordant couples in Taiwan

More information

Success rate of thyroid remnant ablation for differentiated thyroid cancer based on 5550 MBq post-therapy scan

Success rate of thyroid remnant ablation for differentiated thyroid cancer based on 5550 MBq post-therapy scan ORIGINAL ARTICLE Success rate of thyroid remnant ablation for differentiated thyroid cancer based on 5550 MBq post-therapy scan I. Hommel 1 *, G.F. Pieters 1, A.J.M. Rijnders 2, M.M. van Borren 3, H. de

More information

Dynamic Risk Stratification:

Dynamic Risk Stratification: Dynamic Risk Stratification: Using Risk Estimates to Guide Initial Management R Michael Tuttle, MD Clinical Director, Endocrinology Service Memorial Sloan Kettering Cancer Center Professor of Medicine

More information

Approach to Thyroid Nodules

Approach to Thyroid Nodules Approach to Thyroid Nodules Alice Y.Y. Cheng, MD, FRCPC Twitter: @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted

More information

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.

More information

Case 4 Diagnosis 2/21/2011 TGB

Case 4 Diagnosis 2/21/2011 TGB Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.

More information

Title. CitationInternational Cancer Conference Journal, 4(1): Issue Date Doc URL. Rights. Type. File Information

Title. CitationInternational Cancer Conference Journal, 4(1): Issue Date Doc URL. Rights. Type. File Information Title Lymph node metastasis in the suprasternal space from Homma, Akihiro; Hatakeyama, Hiromitsu; Mizumachi, Ta Author(s) Tomohiro; Fukuda, Satoshi CitationInternational Cancer Conference Journal, 4(1):

More information

Disclosures Nodal Management in Differentiated Thyroid Carcinoma

Disclosures Nodal Management in Differentiated Thyroid Carcinoma Disclosures Nodal Management in Differentiated Thyroid Carcinoma Nothing to disclose Jonathan George, MD, MPH Assistant Professor UCSF Head and Neck Oncologic & Endocrine Surgery Objectives Overview Describe

More information

New York, the nation s thyroid gland. Christopher Morley ( ), "Shore Leave"

New York, the nation s thyroid gland. Christopher Morley ( ), Shore Leave New York, the nation s thyroid gland Christopher Morley (1890-1957), "Shore Leave" Thyroid Literature Medline Thyroid disease 136,053 Thyroid tumors 33,554 New Paper on Thyroid Disease Every 3 Hours New

More information

Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer

Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer Well Differentiated Thyroid Cancer Natural History and Prognosis EORTC AGES AMES MACIS QuickTime and a TIFF (LZW) decompressor

More information

Initial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid Cancer

Initial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid Cancer Original Article Initial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid Cancer David Yü Greenblatt, Diane Elson, 1 Eberhard Mack and Herbert Chen, Departments of Surgery

More information

Thyroid carcinoma. Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD D. Brdar, MD, nucl. med. spec.

Thyroid carcinoma. Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD D. Brdar, MD, nucl. med. spec. Thyroid carcinoma Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD D. Brdar, MD, nucl. med. spec. Thyroid tumors PRIMARY TUMORS Tumors of the follicular epithelium : - Tumors of the follicular

More information